Healio3 天
AAAAI president-elect hopes to develop valuable resources, help residents get involved
In his 2025 to 2026 term as American Academy of Allergy, Asthma & Immunology president, Frank S. Virant, MD, FAAAAI, plans to ...
Daily4 天
GSK Depemokimab applications accepted for review in China, Japan for asthma with type 2 ...
GSK plc has announced that new drug applications have been accepted for review by the China National Medical Products ...